-+ 0.00%
-+ 0.00%
-+ 0.00%

Roche Subsidiary TIB MOLBIOL Launches LightMix Newborn TREC/SMN1/HBB Kit To Screen Newborns For SMA, SCID And Sickle Cell Disease Simultaneously

Benzinga·09/30/2026 06:43:02
  • This test expands Roche's early diagnostics portfolio by screening for Spinal Muscular Atrophy (SMA), Severe Combined Immunodeficiency Disease (SCID), and Sickle Cell Disease (SCD) simultaneously.
  • Catching these conditions shortly after birth empowers clinicians to choose life-changing treatments sooner, before irreversible symptoms or permanent damage manifest.
  • The IVDR-approved test provides private and academic hospital laboratories with a ready-to-use solution that easily integrates into existing workflows.